Triple negative breast cancer-BCL2 in prognosis and prediction. Review
        Triple negative breast cancer-BCL2 in prognosis and prediction. Review.        
                  Current Drug Targets.                
                  2014,
                
                              15(12),
                  
                              1166-1175,
                          
                  ISSN: 1389-4501,
                
                
                              PMID: 25374001,